compounded glp 1 vs name brand GLP-1 Compounding: When Innovation May Mean Liability Not Ozempic, not generic: the
Description
Initially focused on managing type 2 diabetes, it would not be until 2014 that Novo Nordisks introduction of another GLP-1 agonist, Saxenda, marked a pivotal shift towards weight loss
Tirzepatide works on two hormone pathways instead of one, which may lead to stronger appetite suppression for some patients
1 References
For these agents to act on posterior segment tissues, they must traverse the formidable BRB, which significantly restricts drug penetration
This is where the value of a telehealth platform becomes clear
10.3389/fnins.2015.00092 Front
